Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
The Motley FoolInvestors shouldn’t assume that all of the company’s future growth is already priced into the stock’s valuation.
Investors shouldn’t assume that all of the company’s future growth is already priced into the stock’s valuation.
